Clinical trial
Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic…
NCT00111618 · Antisoma Research, Industry · Completed
Key facts
| NCT number | NCT00111618 |
|---|---|
| Title | Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer |
| Official title | An Open Label, Randomized, Phase II Study of AS1404 in Combination With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer |
| Lead sponsor | Antisoma Research, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug |
| Interventions | AS1404 (DMXAA) |
| Enrollment | 70 |
| Start date | May 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Aug 1, 2008 |
| First posted | May 25, 2005 |
| Last update posted | Jan 30, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: